Truist analyst David MacDonald raised the firm’s price target on HCA Healthcare to $340 from $325 and keeps a Buy rating on the shares as part of a broader research note on Healthcare Services names. The analyst cites the recent market moves and multiples following commentary from both UnitedHealth (UNH) and Humana (HUM) around an uptick in utilization, reducing targets in Managed Care and bumping Hospital targets while remaining “broadly bullish” on both groups.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HCA:
- HCA Healthcare CFO Cuffe sells 12,556 common shares
- HCA Healthcare price target raised to $275 from $243 at Wells Fargo
- HCA Healthcare price target raised to $345 from $310 at Bernstein
- HCA Healthcare price target raised to $275 from $256 at Barclays
- HCA Healthcare price target raised to $325 from $310 at Truist